MONDELLO, Stefania
 Distribuzione geografica
Continente #
EU - Europa 5.842
NA - Nord America 4.054
AS - Asia 1.239
OC - Oceania 7
SA - Sud America 7
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.158
Nazione #
US - Stati Uniti d'America 4.038
RU - Federazione Russa 2.956
IE - Irlanda 1.161
SE - Svezia 688
CN - Cina 673
SG - Singapore 437
IT - Italia 336
FI - Finlandia 178
PL - Polonia 126
GB - Regno Unito 114
DE - Germania 97
UA - Ucraina 84
IN - India 44
VN - Vietnam 30
BE - Belgio 23
FR - Francia 23
CA - Canada 14
NL - Olanda 14
ID - Indonesia 13
IR - Iran 12
AT - Austria 11
CZ - Repubblica Ceca 11
KR - Corea 8
JP - Giappone 7
AU - Australia 6
BR - Brasile 5
EG - Egitto 5
DK - Danimarca 4
IQ - Iraq 4
RO - Romania 4
CH - Svizzera 3
EU - Europa 3
HU - Ungheria 3
SK - Slovacchia (Repubblica Slovacca) 3
ES - Italia 2
LK - Sri Lanka 2
MX - Messico 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
CO - Colombia 1
GE - Georgia 1
IL - Israele 1
KG - Kirghizistan 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
QA - Qatar 1
SA - Arabia Saudita 1
Totale 11.158
Città #
Moscow 2.943
Dublin 1.159
Chandler 780
Nyköping 379
Singapore 329
Jacksonville 324
Beijing 249
Princeton 242
Medford 218
Dearborn 184
Des Moines 183
Cambridge 175
Ashburn 173
Messina 141
Warsaw 126
Boardman 93
Ann Arbor 89
Wilmington 88
New York 86
Houston 62
Lancaster 57
San Mateo 55
Shenyang 55
Jinan 51
Nanjing 36
Woodbridge 36
Seattle 35
Dong Ket 28
Haikou 28
Tianjin 28
Munich 24
Taizhou 24
Hebei 23
Zhengzhou 23
Pune 22
Brussels 21
Los Angeles 20
Ningbo 17
Rome 16
Nanchang 15
Falls Church 14
Hyderabad 14
Norwalk 14
Hangzhou 13
Jiaxing 13
Brno 11
Jakarta 11
Vienna 11
Fuzhou 10
Washington 10
Changsha 9
Lanzhou 9
Lappeenranta 9
Milan 9
Helsinki 8
Bremen 7
Catania 7
Hefei 7
Tappahannock 7
London 6
Ottawa 6
Paris 6
Taiyuan 6
Miami 5
Redwood City 5
San Francisco 5
Tokyo 5
Arlington 4
Auburn Hills 4
Gainesville 4
New Delhi 4
Phoenix 4
The Dalles 4
Wuhan 4
Cairo 3
Naples 3
Nuremberg 3
Piazza Armerina 3
Riva 3
Santa Clara 3
Seoul 3
Allschwil 2
Ampara 2
Ardabil 2
Augusta 2
Budapest 2
Canberra 2
Castlebar 2
Castrolibero 2
Catanzaro 2
Council Bluffs 2
Fairfield 2
Ferrara 2
Fiumefreddo di Sicilia 2
Giovinazzo 2
Guadalupe 2
Guangzhou 2
Karachi 2
Karaj 2
Kunming 2
Totale 8.961
Nome #
Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury 2.966
Accuracy of Cystosonography without Voiding Phase in the Diagnosis of Vesicoureteral Reflux in Children: A Variant of the Original Technique 97
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 94
Autoantibodies in traumatic brain injury and central nervous system trauma. 91
Emerging markers of cachexia predict survival in cancer patients. 91
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 86
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 86
Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions. 83
Perceived Stress in a Gender Perspective: A Survey in a Population of Unemployed Subjects of Southern Italy 81
Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients 80
Data comparison between pharmacological induction of labour and spontaneous delivery. A single centre experience 78
Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. 77
A Direct Cortico-Nigral Pathway as Revealed by Constrained Spherical Deconvolution Tractography in Humans 77
Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury 76
Nodal Ratio as a Prognostic Factor in Patients with Four or More Positive Axillary Nodes Treated with Breast-conserving Therapy and Regional Nodal Irradiation 76
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 69
p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendroglioma. 66
Glutamine-supplemented total parenteral nutrition improves immunological status in anorectic patients 65
Ubiquitin C-Terminal Hydrolase (UCH-L1): Correlations Exist Between Biofluid Kinetics and Clinical Outcome In Severe Traumatic Brain Injury Patients 65
Quantitative pupillometry and neuron-specific enolase independently predict return of spontaneous circulation following cardiogenic out-of-hospital cardiac arrest: a prospective pilot study 65
Glutamine treatment attenuates the development of ischaemia/reperfusion injury of the gut. 63
alphaII-Spectrin Breakdown Products (SBDPs): Diagnosis and Outcome in Severe Traumatic Brain Injury Patients 62
H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol 61
Bioinformatics approach to understanding interacting pathways in neuropsychiatric disorders. 61
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 61
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 61
Renal complications in oncohematologic patients. 60
Complications of trauma patients admitted to the ICU in level i academic trauma centers in the United States 59
Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial 59
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 58
EFFETTI DEL LAVORO A TURNI E NOTTURNO SU LIVELLI COGNITIVI E STATI DELL’UMORE NEI MEDICI IN FORMAZIONE SPECIALISTICA: DATI PRELIMINARI 58
Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice 57
Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options 57
Hypophosphatemia as unusual cause of ARDS in Cushing's syndrome secondary to ectopic CRH production. A case report 56
Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model 56
Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 55
Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: New insights from a comparative study by MRI and respiratory function assessment 55
High-Dose Robotic Stereotactic Body Radiotherapy in the Treatment of Patients With Prostate Cancer: Preliminary Results in 26 Patients 55
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 55
Anesthetic techniques and cancer recurrence after surgery. 55
Nicotinamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy 54
Lymphocytic vasculitis associated with icodextrin. 53
Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literature. 53
Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats 53
Approach to Modeling, Therapy Evaluation, Drug Selection, and Biomarker Assessments for a Multicenter Pre-Clinical Drug Screening Consortium for Acute Therapies in Severe Traumatic Brain Injury: Operation Brain Trauma Therapy 53
Ubiquitin Carboxy-Terminal Hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure 52
Acute diagnostic biomarkers for spinal cord injury: review of the literature and preliminary research report 52
Psoriasis and cardiovascular risk: correlation between psoriasis and cardiovascular functional indices 52
Method to Detect, Monitor and Promote Neural Regeneration and Improvement of Cognitive Function in a Subject Suffering from Neural Injury 51
Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2 51
Fast Magnetic Resonance Enterography Protocol for the Evaluation of Patients with Crohn's Disease: A Pilot Study 51
Night shift work in resident physicians: does it affect mood states and cognitive levels? 51
Prognostic factors in patients treated with stereotactic image-guided robotic radiosurgery for brain metastases: a single-center retrospective analysis of 223 patients 51
Angiotensin receptor antagonists: a potential neuroprotective strategy after brain trauma*. 50
Biomarkers 50
Biokinetic Analysis of Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in Severe Traumatic Brain Injury Patient Biofluids 50
Blood-based Diagnostics of Traumatic Brain Injury 49
Elevated Levels of Serum Glial Fibrillary Acidic Protein Breakdown Products in Mild and Moderate Traumatic Brain Injury Are Associated With Intracranial Lesions and Neurosurgical Intervention. 49
Quantitative cerebrospinal fluid biokinetic parameters of alpha II-spectrin breakdown products in severe traumatic brain injury patients 49
Assessing Neuro-Systemic & Behavioral Components in the Pathophysiology of Blast-Related Brain Injury. 49
Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats 48
UCH-L1 levels in CSF and Serum: Diagnosis and Outcome in Severe Traumatic Brain Injury Patients 47
Genotoxic effects of anesthetic agents: an update. 47
Preoperative-Induced Mild Hypothermia Attenuates Neuronal Damage in a Rat Subdural Hematoma Model 47
CSF and Plasma Amyloid-b Temporal Profiles and Relationships with Neurological Status and Mortality after Severe Traumatic Brain Injury: Results of a Pilot Study 47
Changes in Brain Biomarkers and Brain Tissue Oxygenation Following Severe Head Injury: A Case Series 46
The hypothalamic-neurohypophyseal system: current and future treatment of vasopressin and oxytocyn related disorders. 46
Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research 46
New astroglial injury-defined biomarkers for neurotrauma assessment 46
The Challenge of Mild Traumatic Brain Injury: Role of Biochemical Markers in Diagnosis of Brain Damage. 45
ECR 2018 - BOOK OF ABSTRACTS 45
CSF protein biomarker panel for assessment of neurotoxicity. 44
A simulated fast magnetic resonance enterography protocol in patients with Crohn's disease: a retrospective, randomized, double-blind study. 44
Development of A TBI Diagnostic Assay System For Multiple Levels Of Care 43
Translating biomarkers research to clinical care: applications and issues for rehabilomics. 43
null 43
Imaging as a biomarker in drug discovery for Alzheimer's disease: Is MRI a suitable technology? 43
ASSESSING A NECROSIS AND APOPTOSIS INDEX USING CSF alpha II-SPECTRIN BREAKDOWN PRODUCT LEVELS IN SEVERE TBI 42
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD) 42
Brain Biomarkers and Brain Tissue Oxygenation: Changes and Correlations Following Severe Head Injury 42
Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. 41
Alpha-synuclein Levels in the Cerebrospinal Fluid of Patients with Parkinson’s Disease and Atypical Parkinsonian Disorders 41
Systems Biology, Bioinformatics, and Biomarkers in Neuropsychiatry 41
Toward Improved Prediction of Outcome In Traumatic Brain Injury: Comparison Between Computed Tomographic Classifications And The Serum Biomarker UCH-L1 40
Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI 40
Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: a comparison with n-acetylcysteine. 40
Family, lifestyles and new and old type of smoking in young adults: insights from an italian multiple-center study 40
Biofluid proteomics and biomarkers in traumatic brain injury 40
Microvascular imaging ultrasound (MicroV) and power Doppler vascularization analysis in a pediatric population with early scrotal pain onset 40
CLINICAL UTILITY OF SERUM LEVELS OF UBIQUITIN C-TERMINAL HYDROLASE AS A BIOMARKER FOR SEVERE TRAUMATIC BRAIN INJURY. 38
Biokinetic Analysis of Ubiquitin C-terminal Hydrolase (uch-l1) In Severe Traumatic Brain Injury Patient Biofluids 38
Extracellular vesicles: pathogenetic, diagnostic and therapeutic value in traumatic brain injury 38
Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk 38
Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity 37
Novel biomarker signatures for idiopathic REM sleep behavior disorder: A proteomic and system biology approach 37
Epidemiology and clinical characteristics of traumatic brain injury in Lebanon A systematic review 37
Cyclosporine Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy 36
Levetiracetam Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy 36
Rodent models of methamphetamine misuse: Mechanisms of methamphetamine action and comparison of different rodent paradigms 36
In vivo monitoring of cytokines and brain biomarker damage following severe traumatic brain injury: a microdialysis study 35
Totale 8.321
Categoria #
all - tutte 48.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.680


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020701 0 0 0 0 6 174 107 82 25 133 156 18
2020/20211.211 60 18 274 45 184 51 18 163 103 172 59 64
2021/20221.220 7 92 18 60 42 15 64 61 18 119 181 543
2022/20233.081 291 191 131 234 207 295 16 162 1.419 21 81 33
2023/20241.716 64 183 55 68 84 187 15 42 7 142 486 383
2024/20252.659 797 786 342 612 122 0 0 0 0 0 0 0
Totale 11.735